Hexaware Technologies, a leading global IT services provider, has announced a strategic partnership with Abluva, an innovator in agentic AI security, to deliver secure and governed Generative AI (GenAI) solutions tailored for the Life Sciences industry. This collaboration is aimed at helping pharmaceutical companies, clinical research organizations (CROs), and healthcare enterprises deploy autonomous AI agents safely, in full compliance with data privacy and industry regulations.

The partnership brings together Hexaware’s vast expertise in clinical research, data management, and digital transformation with Abluva’s Secure Intelligence Plane—a cutting-edge framework designed to manage and monitor GenAI agents throughout their lifecycle. As Life Sciences organizations increasingly explore agentic AI to accelerate research, streamline clinical trials, and optimize patient data workflows, the joint solution ensures these AI agents operate in a secure, auditable, and compliant environment.

Abluva’s Secure Intelligence Plane offers a robust feature set including real-time governance through purpose binding, data masking, tooling control, and role-based context augmentation. These controls are crucial in preventing unauthorized or unsafe actions by autonomous agents. Moreover, the solution integrates advanced threat detection and self-healing mechanisms that automatically identify and respond to anomalies or risks arising from agent behaviors.

The partnership also provides comprehensive agent lifecycle security, covering stages from fine-tuning and Retrieval-Augmented Generation (RAG) to prompt engineering. This approach protects critical life sciences data across research and clinical workflows. Furthermore, the platform is built to uphold stringent compliance with global standards such as HIPAA and GDPR—critical for organizations handling sensitive patient and trial data.

Raj Gondhali, AVP & Head of Clinical Solutions at Hexaware, commented, “This collaboration is pivotal, combining our clinical domain strength with Abluva’s innovation in agentic AI security. It’s a transformative step toward helping our clients adopt AI safely and with full regulatory assurance.”

Echoing this sentiment, Raj Darji, CEO of Abluva, said, “Partnering with Hexaware allows us to scale our secure AI technologies across global life sciences enterprises. This partnership accelerates our mission to ensure that GenAI adoption never comes at the cost of governance or safety.”

Amit Gautam, CTO at Abluva, added, “By integrating our Secure Intelligence Plane with Hexaware’s enterprise-grade systems, we’re solving one of the most critical problems in AI today—governing autonomous agents in regulated environments.”

This partnership marks a significant step in redefining AI deployment in life sciences by embedding compliance and governance into the core of innovation. Together, Hexaware and Abluva are enabling safe, scalable, and intelligent transformation for the future of healthcare and research.

Search Keyword: hexaware technologies, hexaware share, hexaware share price, hexaware stock, hexaware IPO, hexaware share news, hexaware Q1 CY25, hexaware Q4 CY24, hexaware quarterly results, hexaware net profit, hexaware revenue, hexaware earnings, hexaware EBITDA, hexaware PBT, hexaware constant currency growth, hexaware attrition rate, hexaware headcount, hexaware debt, hexaware analyst rating, hexaware target price, hexaware JM Financial, hexaware listing price, hexaware listing gain, hexaware price band, hexaware grey market premium, hexaware revival, hexaware AI services, hexaware digital transformation, hexaware cloud services, hexaware BFSI clients, hexaware healthcare vertical, hexaware deal pipeline, hexaware delivery excellence, hexaware growth outlook, hexaware valuation, hexaware P/E ratio, hexaware market cap, hexaware multibagger prospects, hexaware risk factors, hexaware macro headwinds, hexaware demand softness, hexaware mid‑cap IT peer, hexaware global delivery centers, hexaware new office Chicago, hexaware Egypt, hexaware UK, hexaware Fixie.ai partnership, hexaware IPO subscription, hexaware retail allotment low, hexaware Q1 stock reaction